Archive · 25 Sep 2025
Bartronics Invests in Huwel Life Sciences for Diagnostics
Bartronics India Ltd is investing money in Huwel Life Sciences, a company that creates diagnostic tests.
Bartronics will invest up to ₹50 crore, gaining a 15% stake in Huwel.
Huwel is based in Hyderabad and has approval from Europe and the US.
Huwel makes over 100 diagnostic products, including tests for infections and cancer.
This investment allows Bartronics to enter the molecular diagnostics field.
Bartronics India Ltd (BIL) is investing in Huwel Life Sciences.
BIL will invest up to ₹50 crore to acquire a 15% equity stake.
Huwel Life Sciences is a molecular diagnostics innovator.
Huwel is a women-led private enterprise based in Hyderabad.
Huwel has regulatory approvals from Europe and the US and has developed over 100 diagnostic products.
- Who
- Bartronics India Ltd (BIL) is investing in Huwel Life Sciences.
- What
- BIL is investing up to ₹50 crore to acquire a 15% equity stake in Huwel Life Sciences.
- When
- The investment was published on September 25, 2025.
- Where
- Huwel Life Sciences is located in Hyderabad.
- Why
- The reason for the investment is not explicitly stated, but it is an investment in molecular diagnostics.
- Investor
- Bartronics India Ltd (BIL)
- Investment Amount
- Up to ₹50 crore
- Stake Acquired
- 15%
- Company Invested In
- Huwel Life Sciences
- Industry
- Molecular Diagnostics
- Huwel's Location
- Hyderabad
- Huwel Regulatory Approvals
- Europe, US
- Products Developed
- 100+ diagnostic products